Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunoproteasomal Inhibition With ONX-0914 Attenuates Atherosclerosis and Reduces White Adipose Tissue Mass and Metabolic Syndrome in Mice.
Schaftenaar FH, van Dam AD, de Bruin G, Depuydt MAC, de Mol J, Amersfoort J, Douna H, Meijer M, Kröner MJ, van Santbrink PJ, Bernabé Kleijn MNA, van Puijvelde GHM, Florea BI, Slütter B, Foks AC, Bot I, Rensen PCN, Kuiper J. Schaftenaar FH, et al. Among authors: van santbrink pj. Arterioscler Thromb Vasc Biol. 2024 Jun;44(6):1346-1364. doi: 10.1161/ATVBAHA.123.319701. Epub 2024 Apr 25. Arterioscler Thromb Vasc Biol. 2024. PMID: 38660806
Interference of the CD30-CD30L pathway reduces atherosclerosis development.
Foks AC, Bot I, Frodermann V, de Jager SC, Ter Borg M, van Santbrink PJ, Yagita H, Kuiper J, van Puijvelde GH. Foks AC, et al. Among authors: van santbrink pj, van puijvelde gh. Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2862-8. doi: 10.1161/ATVBAHA.112.300509. Epub 2012 Oct 18. Arterioscler Thromb Vasc Biol. 2012. PMID: 23087358
T-cell immunoglobulin and mucin domain 3 acts as a negative regulator of atherosclerosis.
Foks AC, Ran IA, Wasserman L, Frodermann V, Ter Borg MN, de Jager SC, van Santbrink PJ, Yagita H, Akiba H, Bot I, Kuiper J, van Puijvelde GH. Foks AC, et al. Among authors: van santbrink pj, van puijvelde gh. Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2558-65. doi: 10.1161/ATVBAHA.113.301879. Epub 2013 Aug 29. Arterioscler Thromb Vasc Biol. 2013. PMID: 23990206
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
van der Heijden T, Kritikou E, Venema W, van Duijn J, van Santbrink PJ, Slütter B, Foks AC, Bot I, Kuiper J. van der Heijden T, et al. Among authors: van santbrink pj. Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1457-1461. doi: 10.1161/ATVBAHA.117.309575. Epub 2017 Jun 8. Arterioscler Thromb Vasc Biol. 2017. PMID: 28596375
Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
Bot I, de Vries H, Korporaal SJ, Foks AC, Bot M, van Veldhoven J, Ter Borg MN, van Santbrink PJ, van Berkel TJ, Kuiper J, Ijzerman AP. Bot I, et al. Among authors: van veldhoven j, van berkel tj, van santbrink pj. Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2197-205. doi: 10.1161/ATVBAHA.112.252924. Epub 2012 Jun 28. Arterioscler Thromb Vasc Biol. 2012. PMID: 22743060
An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
Karper JC, de Jager SC, Ewing MM, de Vries MR, Bot I, van Santbrink PJ, Redeker A, Mallat Z, Binder CJ, Arens R, Jukema JW, Kuiper J, Quax PH. Karper JC, et al. Among authors: van santbrink pj. Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2810-7. doi: 10.1161/ATVBAHA.113.301882. Epub 2013 Oct 10. Arterioscler Thromb Vasc Biol. 2013. PMID: 24115036
35 results